While serum C-reactive protein (CRP) concentration has been shown to be higher in CRC patients than in controls in previous studies [34–36], markers such as soluble Tumor Necrosis Factor-α Receptor-1 (sTNFR-1) and sTNFR-2 have never been studied. This evidence concerns the gene CRP and colorectal carcinoma.